-
BioLamina appoints Brian Hawkins, PhD as new Chief Technology Officer (CTO).
Stockholm, March 3, 2025 BioLamina appoints Brian Hawkins, PhD, as new Chief Technology Officer (CTO). BioLamina AB, appoints Brian Hawkins […]
-
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx […]
-
Webinar: Treating Blindness with Stem Cell Therapies
How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the clinic? Join us for the panel discussion!
-
BioLamina AB appoints Klaus Langhoff-Roos as new CEO.
Stockholm August 15, 2024 BioLamina appoints Klaus Langhoff-Roos as new CEO. BioLamina AB, a leading maker of reagents for stem […]
-
Meet us at our next events!
Meet us at our next events Meet us to discuss how we can help you revolutionize cell culture. We will […]
-
BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite
Stockholm May 23rd, 2023 BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite BioLamina announces […]